Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul S Covington

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The American Journal of Gastroenterology|December 7, 2016
Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with DiarrheaBrooks D Cash, Brian E Lacy, Philip S Schoenfeld, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 20, 2002
Ethics and industry-sponsored researchChris Kuebler, Walter S Nimmo, RickenbachJosephH von, et al.
The American Journal of Gastroenterology|April 19, 2017
Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide UseBrian E Lacy, William D Chey, Brooks D Cash, et al.
The American Journal of Gastroenterology|May 31, 2017
Corrigendum: Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide UseBrian E Lacy, William D Chey, Brooks D Cash, et al.
The Journal of Antimicrobial Chemotherapy|June 11, 2013
A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumoniaPaul S Covington, J Michael Davenport, David A Andrae, et al.
Therapeutic Advances in Gastroenterology|April 26, 2019
Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trialsBrian E Lacy, Lucinda A Harris, Lin Chang, et al.
Gastroenterology|April 16, 2013
Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 studyLeonard S Dove, Anthony Lembo, Charles W Randall, et al.
The New England Journal of Medicine|January 21, 2016
Eluxadoline for Irritable Bowel Syndrome with DiarrheaAnthony J Lembo, Brian E Lacy, Marc J Zuckerman, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The American Journal of Gastroenterology|December 7, 2016
Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with DiarrheaBrooks D Cash, Brian E Lacy, Philip S Schoenfeld, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 20, 2002
Ethics and industry-sponsored researchChris Kuebler, Walter S Nimmo, RickenbachJosephH von, et al.
The American Journal of Gastroenterology|April 19, 2017
Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide UseBrian E Lacy, William D Chey, Brooks D Cash, et al.
The American Journal of Gastroenterology|May 31, 2017
Corrigendum: Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide UseBrian E Lacy, William D Chey, Brooks D Cash, et al.
The Journal of Antimicrobial Chemotherapy|June 11, 2013
A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumoniaPaul S Covington, J Michael Davenport, David A Andrae, et al.
Therapeutic Advances in Gastroenterology|April 26, 2019
Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trialsBrian E Lacy, Lucinda A Harris, Lin Chang, et al.
Gastroenterology|April 16, 2013
Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 studyLeonard S Dove, Anthony Lembo, Charles W Randall, et al.
The New England Journal of Medicine|January 21, 2016
Eluxadoline for Irritable Bowel Syndrome with DiarrheaAnthony J Lembo, Brian E Lacy, Marc J Zuckerman, et al.
Pageof 2